Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Renal Failure

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 40 articles: HTML format

Single Articles

June 2026
1. HEERSPINK HJL, Neuen BL, Agarwal R, Cherney DZI, et al
   Finerenone in Persons with Chronic Kidney Disease without Diabetes.
   N Engl J Med. 2026 Jun 4. doi: 10.1056/NEJMoa2604625.
   PubMed     Abstract available
   
   
   
2. HEERSPINK HJL, McGill J, Lawatscheck R
   Finerenone in Type 1 Diabetes and Chronic Kidney Disease. Reply.
   N Engl J Med. 2026;394:2171-2172.
   PubMed    
   
   
   
3. GRANATA A, Corrao S
   Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
   N Engl J Med. 2026;394:2171.
   PubMed    
   
   
   
4. GONZALEZ FM
   Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
   N Engl J Med. 2026;394:2170-2171.
   PubMed    
   
   
   
5. SHAMIM MA, Varthya SB, Singh S
   Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
   N Engl J Med. 2026;394:2170.
   PubMed    
   
   
   March 2026
6. HEERSPINK HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, et al
   Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
   N Engl J Med. 2026;394:947-957.
   PubMed     Abstract available
   
   
   November 2025
7. LOK CE, Farkouh M, Hemmelgarn BR, Moist LM, et al
   Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
   N Engl J Med. 2025 Nov 7. doi: 10.1056/NEJMoa2513032.
   PubMed     Abstract available
   
   
   
8. MC CAUSLAND FR, Charytan DM
   Fish Oil for Patients Receiving Hemodialysis - Red Herring or Great Catch?
   N Engl J Med. 2025 Nov 7. doi: 10.1056/NEJMe2515057.
   PubMed    
   
   
   October 2025
9. AGARWAL R, Rossing P, Mann JFE
   Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply.
   N Engl J Med. 2025;393:1755.
   PubMed    
   
   
   
10. ROMAGNANI P, Soler MJ, Fervenza FC
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed    
    
    
    
11. SILVER S
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed    
    
    
    
12. ASSIL R, Hough A
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1753-1754.
    PubMed    
    
    
    September 2025
13. KAWAI T, Riella LV
    Porcine Xenotransplantation in End-Stage Kidney Disease. Reply.
    N Engl J Med. 2025;393:930-931.
    PubMed    
    
    
    
14. MELILLI E, Garcia Romero E
    Porcine Xenotransplantation in End-Stage Kidney Disease.
    N Engl J Med. 2025;393:930.
    PubMed    
    
    
    
15. WEINRAUCH LA, D'Elia JA
    Porcine Xenotransplantation in End-Stage Kidney Disease.
    N Engl J Med. 2025;393:929-930.
    PubMed    
    
    
    
16. JIANG Q, Ye L, Wu J
    Porcine Xenotransplantation in End-Stage Kidney Disease.
    N Engl J Med. 2025;393:929.
    PubMed    
    
    
    August 2025
17. ZOCCALI C, Mallamaci F
    Combination Therapy for Chronic Kidney Disease and Type 2 Diabetes - A Promising Prelude.
    N Engl J Med. 2025;393:601-602.
    PubMed    
    
    
    June 2025
18. HERRINGTON WG, Staplin N, Haynes R
    Long-Term Effects of Empagliflozin in Chronic Kidney Disease. Reply.
    N Engl J Med. 2025;392:2285-2286.
    PubMed    
    
    
    
19. YOSHIMOTO N, Azegami T, Hayashi K
    Long-Term Effects of Empagliflozin in Chronic Kidney Disease.
    N Engl J Med. 2025;392:2285.
    PubMed    
    
    
    
20. ILANY J
    Long-Term Effects of Empagliflozin in Chronic Kidney Disease.
    N Engl J Med. 2025;392:2284-2285.
    PubMed    
    
    
    
21. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025 Jun 5. doi: 10.1056/NEJMoa2410659.
    PubMed     Abstract available
    
    
    April 2025
22. KOUKOUNAS KG, Dixit MN, Thorsness R, Patzer RE, et al
    Performance of Dialysis Facilities after Health-Equity Scoring Incentive.
    N Engl J Med. 2025;392:1657-1659.
    PubMed    
    
    
    
23. GBADEGESIN RA, Adu D, Ojo A
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans. Reply.
    N Engl J Med. 2025;392:1664.
    PubMed    
    
    
    
24. INGWILLER M
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2025;392:1663-1664.
    PubMed    
    
    
    
25. ZHOU XJ
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2025;392:1663.
    PubMed    
    
    
    February 2025
26. LEAF DE, Bansal N
    Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.
    N Engl J Med. 2025;392:822-823.
    PubMed    
    
    
    
27. KAWAI T, Williams WW, Elias N, Fishman JA, et al
    Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.
    N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2412747.
    PubMed     Abstract available
    
    
    November 2024
28. VIVANTE A
    Genetics of Chronic Kidney Disease. Reply.
    N Engl J Med. 2024;391:1968.
    PubMed    
    
    
    
29. KNEBELMANN B, Haydock L
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1967-1968.
    PubMed    
    
    
    
30. MARCHINI M
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1967.
    PubMed    
    
    
    
31. CHANG KT, Chiu CC, Lin HY
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1966-1967.
    PubMed    
    
    
    
32. PERKOVIC V, Tuttle KR, Pratley R
    Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply.
    N Engl J Med. 2024;391:1757.
    PubMed    
    
    
    
33. DA HORA PASSOS R, Narciso RC, da Silva AA
    Semaglutide for Chronic Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2024;391:1757.
    PubMed    
    
    
    October 2024
34. GBADEGESIN RA, Ulasi I, Ajayi S, Raji Y, et al
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2024 Oct 26. doi: 10.1056/NEJMoa2404211.
    PubMed     Abstract available
    
    
    
35. HERRINGTON WG, Staplin N, Agrawal N, Wanner C, et al
    Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2409183.
    PubMed     Abstract available
    
    
    
36. DURAND CM, Massie A, Florman S, Liang T, et al
    Safety of Kidney Transplantation from Donors with HIV.
    N Engl J Med. 2024;391:1390-1401.
    PubMed     Abstract available
    
    
    August 2024
37. VIVANTE A
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:627-639.
    PubMed    
    
    
    May 2024
38. PERKOVIC V, Tuttle KR, Rossing P, Mahaffey KW, et al
    Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMoa2403347.
    PubMed     Abstract available
    
    
    April 2024
39. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed     Abstract available
    
    
    March 2024
40. XU BP, Wang XT
    Green Dialysis Effluent and Plasma.
    N Engl J Med. 2024;390:e27.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum